Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine
- PMID: 2688654
- DOI: 10.1016/0006-2952(89)90693-x
Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine
Abstract
Tetrahydrodeoxyuridine (dTHU) inhibits deoxycytidine deaminase and, after intracellular phosphorylation to the active 5'-monophosphate, also inhibits deoxycytidylate deaminase (dCMPD). Because in vitro studies have shown that dCMPD may regulate pyrimidine deoxynucleotide metabolism, the objective of this study was to investigate the effects of dTHU on deoxynucleotide metabolism in whole cells. Nearly complete inhibition of dCMPD, measured in intact CCRF-CEM cells by incorporation of [14C]dCyd into dTTP, occurred after a 45-min incubation with 100 microM dTHU. This was accompanied by an 8-fold dCTP pool expansion, although dATP, dTTP, dGTP, and ribonucleoside triphosphate pools were unaffected. Tetrahydrouridine, which inhibits deoxycytidine deaminase exclusively, had no effect on nucleotide pools. The dCTP pool expansion was directly proportional to the dTHU concentration (3-100 microM) and reached a maximum after 2 hr. Inhibition of ribonucleotide reductase by hydroxyurea completely prevented the dTHU-induced dCTP pool expansion, indicating that the substrate of dCMPD was derived from the ribonucleotide pool and that CDP was the predominant precursor of dCTP. dTHU-mediated inhibition of dCMPD appeared reversible. Exposure of cells to 100 microM dTHU followed by washing into fresh medium resulted in a linear decrease of the dCTP pool and an increase in the dTTP pool. The increased dCTP concentration after preincubation with dTHU was associated with an inhibition of deoxycytidine kinase, as indicated by a reduced capacity of cells to phosphorylate ara-C. dTHU is a useful new tool for investigating the role of dCMPD in the regulation of deoxynucleotide metabolism in whole cells.
Similar articles
-
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.Biochem Pharmacol. 1992 Nov 3;44(9):1819-27. doi: 10.1016/0006-2952(92)90077-v. Biochem Pharmacol. 1992. PMID: 1449536
-
Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.Leuk Res. 1991;15(4):205-13. doi: 10.1016/0145-2126(91)90122-a. Leuk Res. 1991. PMID: 2030601
-
Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway.Biochem Cell Biol. 1991 May-Jun;69(5-6):409-14. doi: 10.1139/o91-062. Biochem Cell Biol. 1991. PMID: 1654943
-
Ribonucleotide reductase and deoxyribonucleotide pools.Basic Life Sci. 1985;31:33-45. doi: 10.1007/978-1-4613-2449-2_3. Basic Life Sci. 1985. PMID: 3888178 Review.
-
Changes in deoxynucleoside triphosphate pools induced by inhibitors and modulators of ribonucleotide reductase.Pharmacol Ther. 1985;30(1):31-42. doi: 10.1016/0163-7258(85)90046-4. Pharmacol Ther. 1985. PMID: 3915820 Review.
Cited by
-
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.Cell Cycle. 2017 Jun 3;16(11):1029-1038. doi: 10.1080/15384101.2017.1314407. Epub 2017 Apr 24. Cell Cycle. 2017. PMID: 28436707 Free PMC article.
-
Structure-Guided Synthesis and Mechanistic Studies Reveal Sweetspots on Naphthyl Salicyl Hydrazone Scaffold as Non-Nucleosidic Competitive, Reversible Inhibitors of Human Ribonucleotide Reductase.J Med Chem. 2018 Feb 8;61(3):666-680. doi: 10.1021/acs.jmedchem.7b00530. Epub 2018 Jan 5. J Med Chem. 2018. PMID: 29253340 Free PMC article.
-
Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.Drug Metab Dispos. 2020 Mar;48(3):153-158. doi: 10.1124/dmd.119.089334. Epub 2019 Dec 23. Drug Metab Dispos. 2020. PMID: 31871136 Free PMC article.
-
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.PLoS Med. 2017 Sep 7;14(9):e1002382. doi: 10.1371/journal.pmed.1002382. eCollection 2017 Sep. PLoS Med. 2017. PMID: 28880867 Free PMC article. Clinical Trial.
-
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.Leukemia. 2021 Apr;35(4):1023-1036. doi: 10.1038/s41375-020-1003-x. Epub 2020 Aug 7. Leukemia. 2021. PMID: 32770088 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources